Liu, H., Zask, A., Forouhar, F., Iketani, S., Williams, A., Vaz, D. R., Habashi, D., Choi, K., Resnick, S. J., Hong, S. J., Lovett, D. H., Bai, T., Chavez, A., Ho, D. D., & Stockwell, B. R. (2025). Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening. Nature Communications, 16(1). https://doi.org/10.1038/s41467-024-55421-5

Titanji, B. K., Hazra, A., & Zucker, J. (2024). Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies. JAMA, 332(19), 1652. https://doi.org/10.1001/jama.2024.21091

Fusco, D., Malenica, I., Günthard, H. F., Gupta, S. K., Kurbegov, D., Balani, B., Olender, S., Aberg, J. A., Telep, L. E., Tian, Y., Blair, C., Wu, G., Haubrich, R. H., Wang, C.-Y., Chokkalingam, A. P., Osinusi, A. O., Wendtner, C.-M., & Gottlieb, R. L. (2024). Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies. Clinical Infectious Diseases, 79(5), 1182–1189. https://doi.org/10.1093/cid/ciae336

Duan, Y., Zhou, H., Liu, X., Iketani, S., Lin, M., Zhang, X., Bian, Q., Wang, H., Sun, H., Hong, S. J., Culbertson, B., Mohri, H., Luck, M. I., Zhu, Y., Liu, X., Lu, Y., Yang, X., Yang, K., Sabo, Y., … Yang, H. (2023). Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir. Nature, 622(7982), 376–382. https://doi.org/10.1038/s41586-023-06609-0

Iketani, S., Mohri, H., Culbertson, B., Hong, S. J., Duan, Y., Luck, M. I., Annavajhala, M. K., Guo, Y., Sheng, Z., Uhlemann, A.-C., Goff, S. P., Sabo, Y., Yang, H., Chavez, A., & Ho, D. D. (2022). Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. Nature, 613(7944), 558–564. https://doi.org/10.1038/s41586-022-05514-2

Mgbako, O., Mehta, M., Dietz, D., Neidell, M. J., Huang, S. (Esther), Zucker, J., Shoucri, S., Kubin, C. J., & Castor, D. (2023). Race and Remdesivir: Examination of Clinical Outcomes in a Racially and Ethnically Diverse Cohort in New York City. Ethnicity and Disease, 33(1), 1–8. https://doi.org/10.18865/1653

Liu, H., Iketani, S., Zask, A., Khanizeman, N., Bednarova, E., Forouhar, F., Fowler, B., Hong, S. J., Mohri, H., Nair, M. S., Huang, Y., Tay, N. E. S., Lee, S., Karan, C., Resnick, S. J., Quinn, C., Li, W., Shion, H., Xia, X., … Stockwell, B. R. (2022). Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-29413-2

Chiu, L., Lo, C.-H., Shen, M., Chiu, N., Aggarwal, R., Lee, J., Choi, Y.-G., Lam, H., Prsic, E. H., Chow, R., & Shin, H. J. (2021). Colchicine use in patients with COVID-19: A systematic review and meta-analysis. PLOS ONE, 16(12), e0261358. https://doi.org/10.1371/journal.pone.0261358

Poon, M. M. L., Byington, E., Meng, W., Kubota, M., Matsumoto, R., Grifoni, A., Weiskopf, D., Dogra, P., Lam, N., Szabo, P. A., Ural, B. B., Wells, S. B., Rosenfeld, A. M., Brusko, M. A., Brusko, T. M., Connors, T. J., Sette, A., Sims, P. A., Luning Prak, E. T., … Farber, D. L. (2021). Heterogeneity of human anti-viral immunity shaped by virus, tissue, age, and sex. Cell Reports, 37(9), 110071. https://doi.org/10.1016/j.celrep.2021.110071